Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hepatoblastoma × lenvatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 99 Cholangiocarcinoma 22 Carcinoma, Renal Cell 16 Liver Neoplasms 10 Biliary Tract Neoplasms 9 Stomach Neoplasms 8 Endometrial Neoplasms 7 Breast Neoplasms 7 Thyroid Neoplasms 6 Neoplasms 6 Recurrence 5 Uterine Cervical Neoplasms 4 Melanoma 4 Thyroid Cancer, Papillary 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Cirrhosis, Familial, with Pulmonary Hypertension 3 Advanced Biliary Tract Cancer 3 Adenocarcinoma, Follicular 3 Adenocarcinoma 3 Uveal Melanoma 2 Thyroid Carcinoma, Anaplastic 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Paraganglioma, Extra-Adrenal 2 Mesothelioma, Malignant 2 Liver Diseases 2 Kidney Neoplasms 2

Interventions

Cyclophosphamide 6 Granulocyte Colony-Stimulating Factor 5 Melphalan 4 Etoposide 4 Cisplatin 4 Carboplatin 4 sodium thiosulfate 3 fludarabine 3 Thiotepa 3 Mesna 3 Filgrastim 3 Busulfan 3 pembrolizumab 2 Vorinostat 2 Vincristine 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 Ifosfamide 2 Gemcitabine 2 Fluorouracil 2 Doxorubicin 2 talazoparib 1 sintilimab 1 sargramostim 1 pegylated granulocyte colony-stimulating factor 1 omburtamab I-131 1 lenvatinib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 etoposide phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05322187 2022-04-11

sPLENTY-pc

RenJi Hospital

Phase 2/3 Unknown

Gastrointestinal

Liver Neoplasms, Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡